KIReports

Kidney International Reports | Official journal of @ISNkidneycare | Tweets by KI Reports Social Media team | 👀

[KIReports @KIReports]

🔥KI Reports is excited to report our 2021 impact factor of 6.234!

We would like to thank our readers, authors, editors and reviewers! We could not continue to grow and improve without your continued support

[KIReports @KIReports]

Biopsy-based #Transcriptomics in #Banff 2022 Antibody Mediated Rejection Categories #AMR

#VisualAbstract by @DrAkshayaJ

https://t.co/7mKx27Jy0K

@ikemcz @OViklicky

[Int Society of Nephrology @ISNkidneycare]

📖 This weekend don't miss our @KIReports #ISNFridaySelection: Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE https://t.co/cW94SIJTbK

Grow professionally with the ISN. Access high-impact scientific and clinical research through our journals. Join/renew your ISN membership for the rest of 2026 at 50% off, use code 50ISN26 ➡️ https://t.co/lEI9kBWCY0

#ThisIsISN – Advancing kidney health worldwide. Together.

[𝐋𝐢𝐥𝐢𝐚𝐧 𝐕𝐢𝐥𝐥𝐚𝐥𝐛𝐚 🇦🇷 @LilianCVillalba]

🧬#SmeRenotubularDeFanconiHeredado"Se deben considerar las variantes de 𝗚𝗔𝗧𝗠 en pacientes con anomalías tubulares proximales incompletas o #ERC 𝗶𝗻𝗲𝘅𝗽𝗹𝗶𝗰𝗮𝗯𝗹𝗲".

[KIReports @KIReports]

Genetic #Screening of Patients With Inherited #FanconiSyndrome

#VisualAbstract by @deniise_am

https://t.co/VbSF23Pk1K

[KIReports @KIReports]

#Septic #Shock and Severe #AKI Caused by West Nile Virus in Southern France

https://t.co/ywdNhKyT5A

#KIRNephrologyRounds

[KIReports @KIReports]

Multiplexed Detection of #MembranousNephropathy #Antigens by Multi-Reaction Monitoring #MassSpectrometry

#VisualAbstract by @DrPSVali

https://t.co/VxIjOPLjcB

[KIReports @KIReports]

The Role of #Finerenone in #Cardiorenal Protection and Urine Albumin-to-Creatinine Ratio Modulation

https://t.co/2GiznBJKP6

#KIRReview

[KIReports @KIReports]

https://t.co/VQTGvRdYXp

[KIReports @KIReports]

Happy June!!
Please check out the June @KIReports Issue for the following Issue Highlights and even more!!

https://t.co/35gOW3z9fe

[KIReports @KIReports]

https://t.co/2hncoyGFwn

[KIReports @KIReports]

Correlates of #Pretransplant Outcomes in United States #Kidney #Transplant Programs, 2015-2020

#VisualAbstract by @krishnadoctor1

https://t.co/HSpz1ci3KI

[KIReports @KIReports]

Thin Glomerular Basement Membrane #GBM Phenotypes With no Identified Pathogenic #COL4A3/A4/A5 #Variant

#VisualAbstract by @deniise_am

https://t.co/bJwMjkd5WK

@CzarneckiLab

[KIReports @KIReports]

Systematic Review and Meta-Analysis of #ICU #Scoring Systems Performance in Patients with Pre-Existing #KidneyDisease

#VisualAbstract by @Cteodosiu

https://t.co/kG75bXGdZM

[KIReports @KIReports]

#ABO Blood Types and #Mortality in Patients Undergoing #Hemodialysis

#VisualAbstract by @KajareeG

https://t.co/ZfLZd6aUDd

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Clinical and histologic 🔬 predictors of non-diabetic kidney disease in patients with diabetes mellitus ca. 2026 from @KIReports @Tiff_Caza
#NephJC #Nephpearls

#VisualAbstract by @dra_miliflores

👉 https://t.co/ZXGNZclaNS

[Kenar Jhaveri @kdjhaveri]

AKI After Hepatic Histotripsy - Kidney International Reports https://t.co/zwT1i3eJaL @KIReports

[𝐋𝐢𝐥𝐢𝐚𝐧 𝐕𝐢𝐥𝐥𝐚𝐥𝐛𝐚 🇦🇷 @LilianCVillalba]

➡️Análisis post hoc del ensayo clínico de fase 3 DUPLEX, centrado en la eficacia y seguridad del #Sparsentan en comparación con el irbesartán en pacientes pediátricos con #GEFyS. El #Sparsentan es bien tolerado y produce reducciones de proteinuria clínicamente significativa.

[Int Society of Nephrology @ISNkidneycare]

⚠ @KIReports June issue is out!

Read the latest news in research, highlights from current literature, comprehensive reviews, and in-depth case studies.

https://t.co/zU5FFqD4Fi

#ThisIsISN #Nephrology #Journal #Research #KidneyCommunity #Kidney #OpenAccess